- Home
- JBHT vs NBIX Comparison
JBHT vs NBIX Comparison
Compare JBHT & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBHT
- NBIX
- Stock Information
- Founded
- JBHT 1961
- NBIX 1992
- Country
- JBHT United States
- NBIX United States
- Employees
- JBHT N/A
- NBIX N/A
- Industry
- JBHT Trucking Freight/Courier Services
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JBHT Industrials
- NBIX Health Care
- Exchange
- JBHT Nasdaq
- NBIX Nasdaq
- Market Cap
- JBHT 14.5B
- NBIX 12.0B
- IPO Year
- JBHT N/A
- NBIX 1996
- Fundamental
- Price
- JBHT $138.85
- NBIX $123.02
- Analyst Decision
- JBHT Buy
- NBIX Strong Buy
- Analyst Count
- JBHT 19
- NBIX 20
- Target Price
- JBHT $165.26
- NBIX $163.20
- AVG Volume (30 Days)
- JBHT 1.2M
- NBIX 1.6M
- Earning Date
- JBHT 07-15-2025
- NBIX 05-05-2025
- Dividend Yield
- JBHT 1.27%
- NBIX N/A
- EPS Growth
- JBHT N/A
- NBIX N/A
- EPS
- JBHT 5.52
- NBIX 2.96
- Revenue
- JBHT $12,064,595,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- JBHT $1.78
- NBIX $15.99
- Revenue Next Year
- JBHT $5.67
- NBIX $14.93
- P/E Ratio
- JBHT $25.17
- NBIX $41.60
- Revenue Growth
- JBHT N/A
- NBIX 21.73
- 52 Week Low
- JBHT $122.79
- NBIX $84.23
- 52 Week High
- JBHT $200.40
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- JBHT 48.42
- NBIX 62.85
- Support Level
- JBHT $137.63
- NBIX $117.59
- Resistance Level
- JBHT $140.97
- NBIX $125.63
- Average True Range (ATR)
- JBHT 3.13
- NBIX 2.98
- MACD
- JBHT -0.37
- NBIX -0.02
- Stochastic Oscillator
- JBHT 14.59
- NBIX 72.90
About JBHT J.B. Hunt Transport Services Inc.
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.